TARGED TARGETED ENZYME DELIVERY Trademark

Trademark Overview


On Friday, August 22, 2025, a trademark application was filed for TARGED TARGETED ENZYME DELIVERY with the United States Patent and Trademark Office. The USPTO has given the TARGED TARGETED ENZYME DELIVERY trademark a serial number of 79437611. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 27, 2025. This trademark is owned by TargED Biopharmaceuticals B.V.. The TARGED TARGETED ENZYME DELIVERY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Scientific and technological services; research and development services; laboratory and clinical testing; biotechnology research services; pharmaceutical research services; medical and scientific laboratory services; medical research and development services; research and development in the field of thrombosis treatment; pharmaceutical and biotechnology research for antithrombotic drugs; preclinical and clinical testing of drugs for thrombosis; drug discovery services related to thrombosis; development of biopharmaceuticals for cardiovascular diseases; research in the field of platelet aggregation inhibitors; consultancy services in pharmaceutical research and development; scientific studies related to thrombosis and blood clotting disorders; clinical trials for thrombosis drugs and therapies; design and implementation of drug efficacy studies for thrombosis treatment; genetic research and molecular biology services related to thrombosis; technical data analysis and providing non-down...

Pharmaceutical preparations; medical preparations; dietary supplements for medical purposes; medicinal herbs and extracts; drugs for medical purposes, pharmaceutical preparations for the prevention and treatment of thrombosis; antithrombotic agents; thrombolytic drugs; coagulation inhibitors; anticoagulants; platelet aggregation inhibitors; hemostatic agents; blood thinners for medical use; therapeutic compounds for thrombosis; pharmaceutical preparations for cardiovascular diseases; pharmaceutical preparations for blood clotting disorders; injectable or intravenous solutions for thrombosis treatment; medicinal products for the treatment of deep vein thrombosis (DVT); medicinal products for pulmonary embolism (PE) management; preclinical or clinical trial medicines for thrombosis research; pharmaceuticals for vascular diseases.
targed targeted enzyme delivery

General Information


Serial Number79437611
Word MarkTARGED TARGETED ENZYME DELIVERY
Filing DateFriday, August 22, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, November 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific and technological services; research and development services; laboratory and clinical testing; biotechnology research services; pharmaceutical research services; medical and scientific laboratory services; medical research and development services; research and development in the field of thrombosis treatment; pharmaceutical and biotechnology research for antithrombotic drugs; preclinical and clinical testing of drugs for thrombosis; drug discovery services related to thrombosis; development of biopharmaceuticals for cardiovascular diseases; research in the field of platelet aggregation inhibitors; consultancy services in pharmaceutical research and development; scientific studies related to thrombosis and blood clotting disorders; clinical trials for thrombosis drugs and therapies; design and implementation of drug efficacy studies for thrombosis treatment; genetic research and molecular biology services related to thrombosis; technical data analysis and providing non-downloadable computer software for use in modeling in the field of thrombosis treatment; laboratory services for thrombosis diagnosis and testing; research services related to anticoagulation therapy; research in personalized medicine for thrombosis patients; reference material certification services [quality assessment] in the field of thrombosis treatments; research and development services for biotechnological solutions for thrombosis; scientific advisory and consultation services in thrombosis research.
Goods and ServicesPharmaceutical preparations; medical preparations; dietary supplements for medical purposes; medicinal herbs and extracts; drugs for medical purposes, pharmaceutical preparations for the prevention and treatment of thrombosis; antithrombotic agents; thrombolytic drugs; coagulation inhibitors; anticoagulants; platelet aggregation inhibitors; hemostatic agents; blood thinners for medical use; therapeutic compounds for thrombosis; pharmaceutical preparations for cardiovascular diseases; pharmaceutical preparations for blood clotting disorders; injectable or intravenous solutions for thrombosis treatment; medicinal products for the treatment of deep vein thrombosis (DVT); medicinal products for pulmonary embolism (PE) management; preclinical or clinical trial medicines for thrombosis research; pharmaceuticals for vascular diseases.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTargED Biopharmaceuticals B.V.
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressNL

Trademark Events


Event DateEvent Description
Thursday, November 27, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, November 28, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 28, 2025APPLICATION FILING RECEIPT MAILED